$GH realize that during this pandemic when everyone was afraid to even enter a hospital, let alone vulnerable cancer patients with intentionally weakened immune system due to cancer treatment, yes, they missed estimates and obviously when people don't test, growth is not showing either. Pandemic is over, they have more partnerships, more FDA approved diagnostic test, and on their way to get Lunar approved. All is set perfectly. Fundamentals are as sound as they can be; you want a company that shows profits, GH is the wrong investment for you. GH is a growth company and post pandemic they are set to be that.